Estimating the probability of de novo HD cases from transmissions of expanded penetrant CAG alleles in the Huntington disease gene from male carriers of high normal alleles (27-35 CAG).
about
An Unusually Low Prevalence of Huntington s Disease in IcelandEMQN/CMGS best practice guidelines for the molecular genetic testing of Huntington diseaseCurrent Status of Huntington's Disease in Korea: A Nationwide Survey and National Registry AnalysisCharacterization of a large group of individuals with huntington disease and their relatives enrolled in the COHORT study.Motor-Language Coupling in Huntington's Disease Families.Therapeutic approaches to preventing cell death in Huntington diseaseDominant effects of the Huntington's disease HTT CAG repeat length are captured in gene-expression data sets by a continuous analysis mathematical modeling strategyHD CAG-correlated gene expression changes support a simple dominant gain of function.Anti-PolyQ Antibodies Recognize a Short PolyQ Stretch in Both Normal and Mutant Huntingtin Exon 1.C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts.Intermediate CAG Repeats in Huntington's Disease: Analysis of COHORT.Comparative analysis of anti-polyglutamine Fab crystals grown on Earth and in microgravity.Genetic Contributors to Intergenerational CAG Repeat Instability in Huntington's Disease Knock-In Mice.Exploring the correlates of intermediate CAG repeats in Huntington disease.Huntington's Disease: Relationship Between Phenotype and Genotype.Role of Sigma-1 Receptor in Cocaine Abuse and Neurodegenerative Disease.Genetic counseling and testing for Huntington's disease: A historical review.Tumor necrosis factor receptor-associated factor 6 (TRAF6) associates with huntingtin protein and promotes its atypical ubiquitination to enhance aggregate formation.Huntington's disease: how intermediate are intermediate repeat lengths?High frequency of intermediate alleles on Huntington disease-associated haplotypes in British Columbia's general population.
P2860
Q22306403-507B516D-0FD5-443E-B382-640B12F36A94Q24630629-859FE1B8-3BF1-4AD4-8D9E-9C8449CA1318Q28652090-2079448C-9410-4824-B401-CADFC7503692Q28732051-30CCB1F7-93A8-4439-BC7E-79C83588EDD0Q33743709-A7AC3F51-36E1-4CCE-A9A0-6386F7ACD85CQ34411338-B40F5144-A9B1-4B46-A0C0-2688F066FE2CQ34675885-023F9F1F-F352-4D3A-B708-6780B57C8269Q35056067-0F94A7D1-F22C-4238-8DE6-A115DAD2DA3EQ35904610-0FF0596B-2419-48D0-A411-7F8F9F617D7CQ36198625-419B1864-0A16-4C86-B5AB-5CD217E9D065Q36603022-71FC9288-DE1E-401E-AF67-690C7382E707Q37316264-78DC658C-D0F9-4E49-AFC5-F240DD79F33BQ37621910-596D3928-C227-43BE-9F30-40E0792C280FQ37929502-DFC3F782-E027-4308-B0CF-20072A9F08B8Q38689609-D5BF7310-A9AE-4A45-8341-7809C09603E6Q38743344-C4A08EB8-A979-4689-884D-7D8CCC6B4D97Q38833267-CB43C69C-43DE-4496-AE94-FCE851440B0CQ42813788-E88ACBB7-C344-4542-85DD-D1D70CC3F180Q45290008-595C14F3-244D-47D3-965A-D2930622D8C1Q45295031-A417F9E2-85A6-457A-9E2E-7908937F4E91
P2860
Estimating the probability of de novo HD cases from transmissions of expanded penetrant CAG alleles in the Huntington disease gene from male carriers of high normal alleles (27-35 CAG).
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Estimating the probability of ...... gh normal alleles (27-35 CAG).
@en
Estimating the probability of ...... arriers of high normal alleles
@nl
type
label
Estimating the probability of ...... gh normal alleles (27-35 CAG).
@en
Estimating the probability of ...... arriers of high normal alleles
@nl
prefLabel
Estimating the probability of ...... gh normal alleles (27-35 CAG).
@en
Estimating the probability of ...... arriers of high normal alleles
@nl
P2860
P50
P356
P1476
Estimating the probability of ...... gh normal alleles (27-35 CAG).
@en
P2093
Vanessa Wheeler
P2860
P304
P356
10.1002/AJMG.A.32901
P407
P50
P577
2009-07-01T00:00:00Z